Mirae Asset Global Investments »

Celldex Therapeutics shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 26k 41.97
2023-12-31 $1.0M 26k 39.66
2023-09-30 $696k 25k 27.52
2023-06-30 $917k 27k 33.93
2023-03-31 $918k 26k 35.98
2022-12-31 $870k 20k 44.57
2022-09-30 $549k 20k 28.11
2022-06-30 $371k 14k 26.98